Home / News / India News / Article / Phase II trial of Oxford vaccine candidate to begin in Chandigarh

Phase II trial of Oxford vaccine candidate to begin in Chandigarh

The prerequisites for the candidates eligibility include a minimum age of 18 years, no underlying medical condition and they should not have contracted Covid-19 already

  • WhatsAppBookmarkBookmark
Listen to this article :
This picture has been used for representational purpose only

This picture has been used for representational purpose only

The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate -- Covishield from the first week of September.

The premier institute has received approval from its internal ethical committee and is awaiting the signing of the tripartite agreement between the Indian Council of Medical Research (ICMR) and Serum Institute of India (SII) within the next two days, Madhu Gupta, principal investigator appointee of the vaccine-trial, told IANS.

Read Next Story
Woman's distress mail to UK PM sends MEA, Delhi police into tizzy›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All